Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Vitamin D receptor and analogs.

Adriana S Dusso1, Ravi Thadhani, Eduardo Slatopolsky

  • 1Renal Division, Washington University School of Medicine, St Louis, MO 63110, USA. adusso@im.wustl.edu

Seminars in Nephrology
|January 20, 2004
PubMed
Summary

In chronic kidney disease (CKD), impaired vitamin D (calcitriol) leads to high parathyroid hormone (PTH). Calcitriol analogs can overcome vitamin D resistance and reduce PTH levels in CKD patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Transforming Preeclampsia Care: Molecular Diagnostics and Therapeutic Innovations.

Journal of the American Society of Nephrology : JASN·2026
Same author

Targeted removal of soluble Fms-like tyrosine kinase 1 in very preterm preeclampsia: a pilot trial.

Nature medicine·2026
Same author

Current Controversies on Adequate Circulating Vitamin D Levels in CKD.

International journal of molecular sciences·2026
Same author

Butyrophilin 2A2 promotes T cell immunoregulation via CD45 phosphatase activation and protects against murine autoimmune glomerulonephritis and pregnancy loss.

Nature communications·2026
Same author

Pointing Care for Preeclampsia in the Right Direction.

Hypertension (Dallas, Tex. : 1979)·2025
Same author

Serum soluble-fms-like tyrosine kinase 1-to-placental growth factor ratio on Elecsys immunoassay platform predicts preeclampsia with severe features in hospitalized women with hypertensive disorders of pregnancy.

American journal of obstetrics and gynecology·2025

Area of Science:

  • Nephrology
  • Endocrinology
  • Bone Metabolism

Background:

  • Chronic kidney disease (CKD) is associated with elevated parathyroid hormone (PTH) levels, leading to significant bone disease and cardiovascular complications.
  • Impaired production of 1,25-dihydroxyvitamin D (calcitriol) contributes to parathyroid hyperplasia and increased PTH synthesis in CKD.
  • Calcitriol normally suppresses PTH gene transcription and parathyroid cell proliferation via the TGFα/EGFR pathway.

Purpose of the Study:

  • To investigate the role of vitamin D receptor (VDR) dysfunction in CKD-related hyperparathyroidism.
  • To evaluate the efficacy of calcitriol analogs in overcoming vitamin D resistance in CKD.

Main Methods:

  • Analysis of VDR content and function in parathyroid glands of CKD patients.
  • Assessment of factors impairing VDR function, including hypocalcemia, hyperphosphatemia, uremic toxins, and retinoid X receptor levels.
  • Evaluation of therapeutic outcomes with calcitriol analogs compared to calcitriol.

Main Results:

  • While VDR levels are normal in CKD, parathyroid VDR content is significantly reduced.
  • VDR function is impaired by CKD-specific factors, including hypocalcemia, hyperphosphatemia, and uremic toxins.
  • Calcitriol analogs demonstrate effectiveness in counteracting vitamin D resistance and offer a survival advantage in CKD.

Conclusions:

  • Reduced parathyroid VDR content and impaired VDR function contribute to hyperparathyroidism in CKD.
  • Calcitriol analogs represent a promising therapeutic strategy for managing vitamin D resistance and hyperparathyroidism in CKD patients.
  • Therapy with calcitriol analogs offers a wider therapeutic window and improved outcomes compared to calcitriol alone.

Related Experiment Videos